Becton Dickinson Total Assets 2012-2025 | BDX

Becton Dickinson total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Becton Dickinson total assets for the quarter ending September 30, 2025 were $55.325B, a 3.42% decline year-over-year.
  • Becton Dickinson total assets for 2025 were $55.325B, a 3.42% decline from 2024.
  • Becton Dickinson total assets for 2024 were $57.286B, a 8.54% increase from 2023.
  • Becton Dickinson total assets for 2023 were $52.78B, a 0.29% decline from 2022.
Becton Dickinson Annual Total Assets
(Millions of US $)
2025 $55,325
2024 $57,286
2023 $52,780
2022 $52,934
2021 $53,866
2020 $54,012
2019 $51,765
2018 $53,904
2017 $37,734
2016 $25,586
2015 $26,478
2014 $12,447
2013 $12,149
2012 $11,361
2011 $10,430
Becton Dickinson Quarterly Total Assets
(Millions of US $)
2025-09-30 $55,325
2025-06-30 $54,902
2025-03-31 $54,467
2024-12-31 $54,665
2024-09-30 $57,286
2024-06-30 $55,582
2024-03-31 $54,157
2023-12-31 $52,274
2023-09-30 $52,780
2023-06-30 $53,017
2023-03-31 $54,394
2022-12-31 $53,129
2022-09-30 $52,934
2022-06-30 $53,199
2022-03-31 $54,786
2021-12-31 $53,363
2021-09-30 $53,866
2021-06-30 $54,333
2021-03-31 $54,921
2020-12-31 $54,748
2020-09-30 $54,012
2020-06-30 $53,959
2020-03-31 $53,516
2019-12-31 $51,952
2019-09-30 $51,765
2019-06-30 $52,233
2019-03-31 $52,598
2018-12-31 $52,932
2018-09-30 $53,904
2018-06-30 $53,977
2018-03-31 $54,573
2017-12-31 $55,363
2017-09-30 $37,734
2017-06-30 $37,166
2017-03-31 $24,121
2016-12-31 $24,318
2016-09-30 $25,586
2016-06-30 $26,016
2016-03-31 $26,236
2015-12-31 $26,046
2015-09-30 $26,478
2015-06-30 $27,079
2015-03-31 $28,293
2014-12-31 $18,503
2014-09-30 $12,447
2014-06-30 $12,374
2014-03-31 $12,250
2013-12-31 $12,035
2013-09-30 $12,149
2013-06-30 $11,587
2013-03-31 $11,630
2012-12-31 $11,629
2012-09-30 $11,361
2012-06-30 $11,025
2012-03-31 $11,195
2011-12-31 $11,413
2011-09-30 $10,430
2011-06-30 $10,621
2011-03-31 $10,344
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $57.947B $21.840B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $101.437B 22.66
Cardinal Health (CAH) United States $49.983B 23.61
Straumann Holding AG (SAUHY) Switzerland $19.517B 0.00
West Pharmaceutical Services (WST) United States $18.022B 35.43
Cooper (COO) United States $15.798B 19.52
Align Technology (ALGN) United States $11.878B 22.43
Henry Schein (HSIC) United States $9.151B 16.13
Merit Medical Systems (MMSI) United States $4.844B 23.82
DENTSPLY SIRONA (XRAY) United States $2.404B 7.63
CONMED (CNMD) United States $1.289B 9.21
STAAR Surgical (STAA) United States $1.043B 0.00
Pro-Dex (PDEX) United States $0.136B 16.24
Lifevantage (LFVN) United States $0.076B 7.24
Axe Compute (AGPU) United States $0.020B 0.00